Anti-Inflammatory Effect of Bioflora Probiotic Administered Orally or Subcutaneously with Live or Dead Bacteria
Authors:
- 2 November 2006
- journal article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 51 (12) , 2180-2183
Abstract
The anti-inflammatory effect of Bioflora probiotic administered orally or subcutaneously with viable or nonviable bacteria was analyzed in two experimental models of randomly selected female Wistar rats. The use of indomethacin at a dose of 50 mg/kg was associated with gastric necrotic lesions and multiple erosions of the small intestine, with marked mucosal neutrophil infiltrate measured by myeloperoxidase (MPO). Probiotics prevented both gastrointestinal lesions and neutrophil infiltrate (p < 0.001). In the model of carrageenin-induced plantar edema in the rat, the oral or subcutaneous administration of Bioflora with live or dead bacteria proved to prevent plantar edema (p < 0.001). We concluded that Bioflora probiotic given orally or subcutaneously with live or dead bacteria has an anti-inflammatory effect.Keywords
This publication has 22 references indexed in Scilit:
- Probiotics for the Developing WorldJournal of Clinical Gastroenterology, 2005
- Evaluation of Five Probiotic Products for Label Claims by DNA Extraction and Polymerase Chain Reaction AnalysisDigestive Diseases and Sciences, 2005
- Erratum to: Evaluation of Five Probiotic Products for Label Claims by DNA Extraction and Polymerase Chain Reaction AnalysisDigestive Diseases and Sciences, 2005
- Overcoming the technological hurdles in the development of probiotic foodsJournal of Applied Microbiology, 2005
- Probiotics Ameliorate Recurrent Th1-Mediated Murine Colitis by Inducing IL-10 and IL-10-Dependent TGF-β-Bearing Regulatory CellsThe Journal of Immunology, 2005
- Lactobacillus and bifidobacterium in irritable bowel syndrome: Symptom responses and relationship to cytokine profilesGastroenterology, 2005
- Probiotics: wanted dead or aliveDigestive and Liver Disease, 2005
- Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazineGut, 2004
- Bacillus clausii Probiotic StrainsJournal of Clinical Gastroenterology, 2004
- Is the mucosal route of administration essential for probiotic function? Subcutaneous administration is associated with attenuation of murine colitis and arthritisGut, 2004